Evidence map›Paper›PMID 27671377›Full record

ArticleScientific reports2016

Biocompatibility and biodistribution of functionalized carbon nano-onions (f-CNOs) in a vertebrate model.

Marta D' Amora, Marina Rodio, Juergen Bartelmess, Giuseppe Sancataldo, Rosaria Brescia, Francesca Cella Zanacchi, Alberto Diaspro, Silvia Giordani

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Biocompatibility of nanomaterials and their immunological properties.Biomedical materials (Bristol, England) · 2021
    Review
  7. Article
  8. Article
  9. Modulation of Efficient Diiodo-BODIPYFrontiers in chemistry · 2020
    Article
  10. Article
  11. Article
  12. Zebrafish as a Model to Evaluate Nanoparticle Toxicity.Nanomaterials (Basel, Switzerland) · 2018
    Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marta D' AmoraOptical Nanoscopy, Nanophysics, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, 16163, Italy.
Marina RodioNano Carbon Materials, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, 16163, Italy.
Juergen BartelmessNano Carbon Materials, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, 16163, Italy.
Giuseppe SancataldoOptical Nanoscopy, Nanophysics, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, 16163, Italy.
Rosaria BresciaNanochemistry Department, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, 16163, Italy.
Francesca Cella ZanacchiOptical Nanoscopy, Nanophysics, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, 16163, Italy.
Alberto DiasproOptical Nanoscopy, Nanophysics, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, 16163, Italy.
Silvia GiordaniNano Carbon Materials, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, 16163, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functionalized carbon nano-onions (f-CNOs) are of great interest as platforms for imaging, diagnostic and therapeutic applications due to their high cellular uptake and low cytotoxicity. To date, the toxicological effects of f-CNOs on vertebrates have not been reported. In this study, the possible biological impact of f-CNOs on zebrafish during development is investigated, evaluating different toxicity end-points such as the survival rate, hatching rate, and heart beat rate. Furthermore, a bio-distribution study of boron dipyrromethene (BODIPY) functionalized CNOs in zebrafish larvae is performed by utilizing inverted selective plane illumination microscopy (iSPIM), due to its intrinsic capability of allowing for fast 3D imaging. Our in vivo findings indicate that f-CNOs exhibit no toxicity, good biocompatibility (in the concentration range of 5-100 μg mL

Identifiers

PMID27671377
PMCPMC5037369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.